272
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma

, , , , &
Pages 3113-3122 | Accepted 15 Oct 2007, Published online: 12 Nov 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Christopher KM Hui & Kian F Chung. (2011) Indacaterol: pharmacologic profile, efficacy and safety in the treatment of adults with COPD. Expert Review of Respiratory Medicine 5:1, pages 9-16.
Read now
Carola Seifart & Claus Vogelmeier. (2009) Emerging drugs in chronic obstructive pulmonary disease. Expert Opinion on Emerging Drugs 14:1, pages 181-194.
Read now

Articles from other publishers (19)

Sanket M. Patil, Sagar S. Kale, Ashwini R. Pawar & Ashwini R. Pawar. (2023) Development and Validation of Stability Indicating UV Spectrophotometric Method for Simultaneous Estimation of Indacaterol and Momestasone Furoate in Pharmaceutical Dosage Form. International Journal of Advanced Research in Science, Communication and Technology, pages 1-10.
Crossref
Mario Cazzola, Paola Rogliani & Maria Gabriella Matera. (2019) Ultra-LABAs for the treatment of asthma. Respiratory Medicine 156, pages 47-52.
Crossref
Peter Strong, Kazuhiro Ito, John Murray & Garth Rapeport. (2018) Current approaches to the discovery of novel inhaled medicines. Drug Discovery Today 23:10, pages 1705-1717.
Crossref
Jutta Beier & Kai M. Beeh. 2014. Indacaterol. Indacaterol 67 76 .
Alexandre Trifilieff, Steven J. Charlton & Robin A. Fairhurst. 2014. Indacaterol. Indacaterol 25 37 .
Shaunta' M. Ray, James C. McMillen, Sarah A. Treadway, Robert S. Helmer & Andrea S. Franks. (2012) Indacaterol: A Novel Long‐Acting β 2 ‐Agonist . Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:5, pages 456-474.
Crossref
David A Sykes & Steven J Charlton. (2012) Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonists. British Journal of Pharmacology 165:8, pages 2672-2683.
Crossref
Mario Cazzola & Maria Gabriella Matera. 2012. Advances in Combination Therapy for Asthma and COPD. Advances in Combination Therapy for Asthma and COPD 81 101 .
Federico L Dente, Elena Bacci, Barbara Vagaggini & Pierluigi Paggiaro. (2011) Role of indacaterol in the management of asthma and chronic obstructive pulmonary disease. Clinical Investigation 1:4, pages 589-602.
Crossref
Nadia S. Brienza, Óscar Amor-Carro & David Ramos-Barbón. (2010) An update on the use of indacaterol in patients with COPD. Therapeutic Advances in Respiratory Disease 5:1, pages 29-40.
Crossref
Naruhiko Sugihara, Shigeto Kanada, Michiko Haida, Masakazu Ichinose, Mitsuru Adachi, Motoi Hosoe, Charlotte Emery, Mark Higgins & Benjamin Kramer. (2010) 24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: A comparison with placebo and salmeterol. Respiratory Medicine 104:11, pages 1629-1637.
Crossref
Elizabeth M. Rosethorne, Robert J. Turner, Robin A. Fairhurst & Steven J. Charlton. (2010) Efficacy is a contributing factor to the clinical onset of bronchodilation of inhaled β2-adrenoceptor agonists. Naunyn-Schmiedeberg's Archives of Pharmacology 382:3, pages 255-263.
Crossref
François Baur, David Beattie, David Beer, David Bentley, Michelle Bradley, Ian Bruce, Steven J. Charlton, Bernard Cuenoud, Roland Ernst, Robin A. Fairhurst, Bernard Faller, David Farr, Thomas Keller, John R. Fozard, Joe Fullerton, Sheila Garman, Julia Hatto, Claire Hayden, Handan He, Colin Howes, Diana Janus, Zhengjin Jiang, Christine Lewis, Frederique Loeuillet-Ritzler, Heinz Moser, John Reilly, Alan Steward, David Sykes, Lauren Tedaldi, Alexandre Trifilieff, Morris Tweed, Simon Watson, Elke Wissler & Daniel Wyss. (2010) The Identification of Indacaterol as an Ultralong-Acting Inhaled β 2 -Adrenoceptor Agonist . Journal of Medicinal Chemistry 53:9, pages 3675-3684.
Crossref
Mario Cazzola, Andrea Segreti & Maria G Matera. (2010) Novel bronchodilators in asthma. Current Opinion in Pulmonary Medicine 16:1, pages 6-12.
Crossref
Keir E. Lewis & Gwyneth A. Davies. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions 311 331 .
Kai M. Beeh & Jutta Beier. (2009) Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases. Advances in Therapy 26:7, pages 691-699.
Crossref
. (2009) Current World Literature. Current Opinion in Pulmonary Medicine 15:1, pages 79-87.
Crossref
M Cazzola & M G Matera. (2008) Novel long-acting bronchodilators for COPD and asthma. British Journal of Pharmacology 155:3, pages 291-299.
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.